Glaucoma damages the optic nerve slowly and silently, which is why monitoring is the heart of glaucoma care. For years, doctors have tracked the disease with two main tools: structural OCT scans of the nerve fiber layer and visual field tests that map side vision. A new study suggests a third tool, OCT angiography (OCT-A), may sometimes pick up change even earlier.
What OCT-A measures
Standard OCT measures the thickness of the retinal nerve fiber layer around the optic nerve. OCT-A uses the same kind of scan to map tiny blood vessels, reporting how dense the capillary network is around the nerve. The idea is that blood vessel changes might show up before the nerve fibers are visibly lost.
What the study found
Researchers at the Shiley Eye Institute, publishing in JAMA Ophthalmology, reviewed 180 eyes from 116 patients in the long-running Diagnostic Innovations in Glaucoma Study. At least one test detected progression in 107 eyes.
- Among eyes that progressed on both measures, OCT-A vessel density changes came before visual field worsening by an average of 2.3 years.
- Standard OCT nerve fiber thinning came before visual field worsening by about 1.5 years.
- Nerve fiber thinning was more often the first sign in very early glaucoma, while vessel density loss was more often first in more established disease.
The trade-off: false alarms
Earlier detection only helps if it is accurate. In 45 clinically stable eyes, OCT-A flagged “progression” 31.1% of the time compared with 24.4% for standard OCT. In other words, OCT-A was less specific. The lead researcher said the results support a multimodal approach, with OCT-A adding information rather than replacing OCT or visual fields, especially when the other tests disagree. A University of Houston expert who reviewed the study urged caution, noting that the vessel density measure is not interchangeable across devices and that, for now, a decline is better treated as a reason for closer watching than as proof of progression.
What this means for patients
No single test tells the whole story. Different tests caught progression in different eyes and at different times. For patients, the practical lessons are:
- Keep every scheduled visit; trends over time matter more than any one scan.
- Expect your doctor to use more than one test, and ask how your results compare with last time.
- Use your drops exactly as prescribed, even when your vision feels fine.
- If glaucoma runs in your family, start regular exams early.
Our role
Khanna Vision Institute provides glaucoma evaluation and ongoing monitoring for patients across the San Fernando Valley, including Encino, Sherman Oaks, and Tarzana, at our Beverly Hills and Westlake Village offices.
Screen-heavy students and commuters can find tips on eye comfort and glaucoma basics at Moorpark Lasik.
Source: OCT-A may detect glaucoma progression earlier than OCT, visual field testing (Healio, 10/14/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.